Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Entrectinib: A Promising Treatment for NTRK Fusion-Positive Solid Tumors
Entrectinib has demonstrated durable and clinically meaningful responses in patients with NTRK fusion-positive solid tumors. It was well tolerated and exhibited a manageable safety profile. These results indicate that entrectinib is a safe and effective treatment option for patients with NTRK fusion-positive solid tumors.
Furthermore, these findings underscore the importance of routinely testing for NTRK fusions to expand the therapeutic options available for these patients..
…